Sharon M Moe1,2. 1. Division of Nephrology, Indiana University School of Medicine, 950 W. Walnut Street, R2-202, Indianapolis, IN, 46202, USA. smoe@iu.edu. 2. Department of Medicine, Roudebush Veterans Affairs Medical Center, Indianapolis, IN, USA. smoe@iu.edu.
Abstract
PURPOSE OF REVIEW: Chronic kidney disease (CKD) affects nearly 10% of the population. The incidence of fractures in population studies demonstrate an increase with worsening stages of kidney disease suggesting specific CKD related causes of fracture. RECENT FINDINGS: The increase in fractures with CKD most likely represents disordered bone quality due to the abnormal bone remodeling from renal osteodystrophy. There is also an increase in fractures with age in patients with CKD, suggesting that patients with CKD also have many fracture risk factors common to patients without known CKD. Osteoporosis is defined by the National Institutes of Health as "A skeletal disorder characterized by compromised bone strength predisposing to an increased risk of fracture. Bone strength reflects the integration of two main features: bone quantity and bone quality." Thus, CKD-related fractures can be considered a type of osteoporosis-where the bone quality is additionally impaired above that of age/hormonal-related osteoporosis. Perhaps using the term CKD-induced osteoporosis, similar to steroid-induced osteoporosis, will allow patients with CKD to be studied in trials investigating therapeutic agents. In this series, we will examine how CKD-induced osteoporosis may be diagnosed and treated.
PURPOSE OF REVIEW: Chronic kidney disease (CKD) affects nearly 10% of the population. The incidence of fractures in population studies demonstrate an increase with worsening stages of kidney disease suggesting specific CKD related causes of fracture. RECENT FINDINGS: The increase in fractures with CKD most likely represents disordered bone quality due to the abnormal bone remodeling from renal osteodystrophy. There is also an increase in fractures with age in patients with CKD, suggesting that patients with CKD also have many fracture risk factors common to patients without known CKD. Osteoporosis is defined by the National Institutes of Health as "A skeletal disorder characterized by compromised bone strength predisposing to an increased risk of fracture. Bone strength reflects the integration of two main features: bone quantity and bone quality." Thus, CKD-related fractures can be considered a type of osteoporosis-where the bone quality is additionally impaired above that of age/hormonal-related osteoporosis. Perhaps using the term CKD-induced osteoporosis, similar to steroid-induced osteoporosis, will allow patients with CKD to be studied in trials investigating therapeutic agents. In this series, we will examine how CKD-induced osteoporosis may be diagnosed and treated.
Authors: John Wagner; Kenar D Jhaveri; Lisa Rosen; Suzanne Sunday; Anna T Mathew; Steven Fishbane Journal: Nephrol Dial Transplant Date: 2013-09-26 Impact factor: 5.992
Authors: Anne C Beaubrun; Ryan D Kilpatrick; Janet K Freburger; Brian D Bradbury; Lily Wang; M Alan Brookhart Journal: J Am Soc Nephrol Date: 2013-06-06 Impact factor: 10.121
Authors: A M Alem; D J Sherrard; D L Gillen; N S Weiss; S A Beresford; S R Heckbert; C Wong; C Stehman-Breen Journal: Kidney Int Date: 2000-07 Impact factor: 10.612
Authors: Zhimin Chen; Abdul Rashid Qureshi; Jonaz Ripsweden; Lars Wennberg; Olof Heimburger; Bengt Lindholm; Peter Barany; Mathias Haarhaus; Torkel B Brismar; Peter Stenvinkel Journal: Bone Date: 2016-08-09 Impact factor: 4.398
Authors: Ken Iseri; Abdul Rashid Qureshi; Jonaz Ripsweden; Olof Heimbürger; Peter Barany; Ingrid B Bergström; Peter Stenvinkel; Torkel B Brismar; Bengt Lindholm Journal: J Bone Miner Metab Date: 2020-09-04 Impact factor: 2.626
Authors: Ludmila Brunerová; Petr Kasalický; Jana Verešová; Renata Lažanská; Jana Potočková; Ivan Rychlík Journal: Int Urol Nephrol Date: 2020-02-03 Impact factor: 2.370
Authors: K S Bezerra de Carvalho; R F V Vasco; M R Custodio; V Jorgetti; R M A Moysés; R M Elias Journal: Osteoporos Int Date: 2019-01-28 Impact factor: 4.507
Authors: Ludmila Brunerová; Renata Lažanská; Petr Kasalický; Jana Verešová; Jana Potočková; Alena Fialová; Ivan Rychlík Journal: Int Urol Nephrol Date: 2018-08-16 Impact factor: 2.370
Authors: Thomas F Hiemstra; Jane C Smith; Kenneth Lim; Dihua Xu; Shreya Kulkarni; J Andrew Bradley; Kaido Paapstel; Inez Schoenmakers; John R Bradley; Laurie Tomlinson; Carmel M McEniery; Ian B Wilkinson Journal: PLoS One Date: 2020-07-07 Impact factor: 3.240